We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
SurModics, a provider of surface modification and drug delivery technologies
to the medical device industry, has made an equity investment of approximately
$3.9 million in OctoPlus, a privately owned company based in the Netherlands
active in the development of pharmaceutical formulations incorporating novel
biodegradable polymers.
Chembio Diagnostics has filed a new patent application with the U.S. Patent
and Trademark Office for a novel method and device incorporating lateral flow
technology, which the company believes provides it with a proprietary platform
upon which it will be able to develop several new rapid tests.
Rubicor Medical, maker of the EnCapsule minimally invasive breast biopsy devices,
has announced that the lawsuit filed against it by Neothermia for breach of
contract and patent infringement has been dismissed.
Lumera has received the third in a series of patents
covering the company's fundamental technology. This patent family protects the
highly efficient electro-optic materials and devices that Lumera is developing
and bringing to market.
Advanced Sterilization Products, a developer of instrument processing technologies,
has announced the Canadian launch of the STERRAD NX Sterilization System, its
next-generation low-temperature hydrogen peroxide gas plasma sterilizer for
rapid processing of medical devices and surgical instruments.
The MedSystems business unit of VIASYS, a provider of enteral feeding devices,
recently received FDA clearance to market the CORTRAK system, a patented device
designed to aid in the placement of enteral feeding tubes.
One-hundred percent of people facing almost-certain amputation were successfully
treated with a new nonsurgical therapy that gently cools and opens leg arteries
clogged with plaque, according to preliminary data on 22 patients presented
at the 17th Annual International Symposium on Endovascular Therapy.
Mark McClellan, administrator of the Centers for Medicare & Medicaid Services
(CMS), said the agency was "poised to expand" coverage of implantable
cardioverter-defibrillators (ICDs) based on new research showing they could
increase the chances of survival in substantial numbers of elderly people on
Medicare.
Synovis has announced publication of data showing that using Peri-Strips, the
company's biomaterial buttress, to reinforce the staple line during laparoscopic
gastric bypass surgery reduced the possibility of acute staple-line failure
and gastrointestinal leakage.
Hydrogel Design Systems, a subsidiary of Nesco Industries, is in the process
of completing the first order under a supply agreement with Vyteris signed on
Dec. 27, 2004.